<DOC>
	<DOCNO>NCT02200146</DOCNO>
	<brief_summary>The aim study determine non-inferiority overall success rate safety combination therapy hydroxychloroquine plus low dose glucocorticoid compare high dose glucocorticoid 3 9 month patient pulmonary sarcoidosis .</brief_summary>
	<brief_title>Hydroxychloroquine Steroid-Sparing Agent Pulmonary Sarcoidosis ( HySSAS ) .</brief_title>
	<detailed_description />
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Sarcoidosis , Pulmonary</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>patient 18 70 year parenchymal pulmonary involvement Chest XRay ( CXR ) AND one follow : physiologic abnormality pulmonary function test and/or respiratory symptom , and/or exerciseinduced abnormality . Unable understand protocol sign inform consent suitable candidate comply requirement study , opinion investigator Cardiac neurological sarcoidosis organ involvement End stage lung disease highresolution compute tomography ( HRCT ) Clinical evidence active infection Documented exposure beryllium Patients Forced Expiratory Volume one second ( FEV1 ) change salbutamol inhalation â‰¥20 % Comorbidity : advanced liver cirrhosis abnormal liver function , unstable cardiac disease , moderate severe renal insufficiency , poorly control diabetes Pregnancy lactation A tuberculin skin test ( 5 I.U . ) 5 mm Psoriasis Homozygous glucose6phosphatase deficiency Known hypersensitivity hydroxychloroquine 4aminoquinoline derivative Visual field change attributable 4aminoquinolines Concomitant therapy : patient enrol study must prohibit medication least 4 week screen . Once patient complete washout period , may enter screen period may last 30 day Previous therapy : patient enrol must medication sarcoidosis least 4 week screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>sarcoidosis</keyword>
	<keyword>treatment</keyword>
	<keyword>lung</keyword>
	<keyword>glucocorticoid</keyword>
	<keyword>hydroxychloroquine</keyword>
</DOC>